Drug Profile
SSS 17
Alternative Names: HIF-117; HIF-PH inhibitor; SSS-17Latest Information Update: 05 Apr 2023
Price :
$50
*
At a glance
- Originator 3SBio
- Class Antianaemics; Small molecules
- Mechanism of Action EGLN2 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Anaemia